На главную
Результаты поиска “Coumadin for atrial fibrillation”
Anticoagulation strategies for Atrial Fibrillation [UndergroundMed]
For more videos, check out our website at: http://videos.undergroundmed.net
Просмотров: 2383 UndergroudMed
Atrial fibrillation -- achieving safer anticoagulation
Sunil Rao John Alexander
Просмотров: 180 Duke Clinical Research Institute
Atrial Fibrillation, Coumadin®, & the CHADS2 Score--StopAfib.org interviews Dr. Manish Shah
http://www.stopafib.org If you have atrial fibrillation, how do you know your risk of stroke and whether or not you should be taking Coumadin® or warfarin? Dr. Manish Shah talks about the CHADS2 scoring system that addresses this afib controversy and how your doctor will assess your CHADS2 score. Dr. Shah is an electrophysiologist, Associate Director of Cardiac Arrhythmia Research at the Washington Hospital Center in Washington, D.C., and Assistant Professor of Medicine at Georgetown University School of Medicine. StopAfib.org, at http://www.StopAfib.org, is for atrial fibrillation patients by afib patients. A full video transcript can be found at: http://stopafib.org/newsitem.cfm/NEWSID/135
Просмотров: 5818 StopAfib
New Anticoagulants for Stroke Prevention in Atrial Fibrillation | Christian Ruff, MD
"New Anticoagulants for Stroke Prevention in Atrial Fibrillation" Christian Ruff, MD Treatment Options for Atrial Fibrillation and VTE March 4th, 2013 Brigham and Women's Hospital Boston, MA
Просмотров: 11222 NAThrombosisForum
NOACs should replace warfarin in all patients with atrial fibrillation - Pro - J. Camm
This video was recorded during the ESC Heart & Brain workshop course held at Charles University in Prague, Czech Republic. The goal of this first edition of this workshop was to bring together leading experts in the field of stroke and cardiologists, neurologists, radiologists, surgeons and other specialists to learn from each other. Find out more about the ESC Council on Stroke: https://www.escardio.org/Councils/Council-on-Stroke?hit=youtube
Просмотров: 243 European Society of Cardiology
Goals of treating atrial fibrillation. Rhythm vs rate control and anticoagulation.
Description of goals of treating atrial fibrillation. Rhythm vs rate control and anticoagulation.
Просмотров: 931 Diego Belardi
9 atrial fibrillation Anticoagulation
Просмотров: 1271 drsarmaji
Atrial fibrillation: 2 key managment issues explained
In this video we try to explain two of the key issues for the management of atrial fibrillation. 1.The first issue is the issue of heart rate control versus heart rhythm control. Will your physician try to just control your heart rate or try to flip your rhythm back in to sinus rhythm from atrial fibrillation? With heart rate control our goal is to try to control the heart rate only. Thus the patient could still be in atrial fibrillation however heart rate is brought under control (60-110 bpm) with medications like beta blockers- metoprolol and calcium channel blockers like diltiazem etc. By rhythm control the physician tries to reset the heart into into sinus rhythm from atrial fibrillation. This can be done with the help of medications and is called as chemical cardioversion. Or it can be done by electrical shock also known as electrical cardioversion. Medications that can be used to keep the patient in the rhythm. These medications include, flecanide, sotalol or amiodarone etc. 2. The second key issue in the management of atrial fibrillation is prevention of stroke. Stroke is a deadly complication of atrial fibrillation. The first question that arises is what is the risk of stroke in a given patient with atrial fibrillation. A patients risk of stroke can be calculated by using an abbreviation called CHAD2VASC2 (explained in the table). Blood thinners (like Coumadin or newer agents like xeralto/apixaban/rivaroxaban) are recommended for patients with a score more than 2. For a score of zero usually no blood are recommended and for patients with the score of one either blood thinner or are aspirin as recommended. If you like this video and would like to see more of such patient educational videos go to our website www.patienteducationpro.com.
Просмотров: 1702 PatientEducationPro
How to Assess and Manage Stroke Risk in Atrial Fibrillation
In this video first seen on Medscape Cardiology, Mayo Clinic electrophysiologist Paul Friedman, M.D., and neurologist James Klaas, M.D., discuss how to manage stroke risk in atrial fibrillation. For more information on atrial fibrillation or to request an appointment, visit https://www.mayoclinic.org/diseases-conditions/atrial-fibrillation/symptoms-causes/syc-20350624?mc_id=global&utm_source=youtube&utm_medium=sm&utm_content=dysrhythmiaheart&utm_campaign=mayoclinic&geo=global&placementsite=enterprise&cauid=103944. Risk scoring systems are used to determine which patients have a high enough stroke risk to warrant treatment. The most commonly used scoring system for atrial fibrillation stroke risk is the CHA2DS2VASc score. Approximately 20% of stokes come from the heart, however, there are other etiologies including carotid arteries, vertebral arteries, arterial dissections, and atherosclerosis. Outline: • Introduction • Assessing stroke risk in atrial fibrillation (0:26) • The CHADS-VASc score of 1 dilemma (2:09) • Other risk factors for stroke in patients with atrial fibrillation (6:22) • When not to anticoagulate (8:12) • Cerebral amyloid angiopathy risk in atrial fibrillation (9:48) • Nonmedical means of preventing stroke (13:12) • Conclusion (16:15)
Просмотров: 414 Mayo Clinic
Warfarin vs NOACs for Anticoagulation in AF: key points in 120 seconds
😀 Learn fast with Dr. Aman Arora's videos! 🌎 Website: https://aroramedicaleducation.co.uk ‪#aroraBites #CanPassWillPass #iWentWithArora ------------------------------------- 👌 This video: ‪💊💊💊 Warfarin vs NOACs for Anticoagulation in AF: key points in 120 seconds Source/details: https://cks.nice.org.uk/atrial-fibrillation#!scenariorecommendation:4 *not for medical advice* --------------------------------------- 🙋‍♂️ Find out more about Dr. Aman: (https://aroramedicaleducation.co.uk/meet-aman/) 🙌 JOIN DR. AMAN ON HIS OTHER STREAMS FOR MORE FREE MEDICAL EDUCATION: 😳 Busy? Subscribe to #aroraCondensed: Aman’s fortnightly teaching emails direct to your inbox: http://eepurl.com/duAwXr ✅ Flagship Facebook Medical Education group: (https://www.facebook.com/groups/aroraMedicalExamSupport/) ✅ Facebook Page: (https://www.facebook.com/arorameded/) ✅ Instagram: @dr_aman_arora (https://www.instagram.com/dr_aman_arora/) ✅ Twitter: @aman999arora (https://mobile.twitter.com/aman999arora) ✅ SoundCloud: Dr Aman Arora (https://soundcloud.com/user-121278599) -------------------------------- 🌎 Website: https://aroramedicaleducation.co.uk 💥 Immersion Courses 💥 Mock Exams 💥 Live Webinars 💥 Audiobooks 💥 Online Training 💥 One-to-one Sessions 💥 Questions and Cases 💥 Revision Posters ----------------------------------- *All videos are for educational purposes only and are not to be used for medical advice* *No medical advice can be given on this channel - appropriate qualified medical advice should be sought for clinical or healthcare queries* *Guidance is aimed to be relevant and up-to-date at time of release*
Просмотров: 1010 Aman Arora
Afib: Perioperative Management of Anticoagulation: 2016 AF Guidelines
Perioperative Management of Anticoagulation in Patients with AF 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Featuring: L. Brent Mitchell, MD Libin Cardiovascular Institute of Alberta University of Calgary, and Alberta Health Services
Просмотров: 2130 Canadian Cardiovascular Society
Atrial Fibrillation Patients Are at Increased Risk of Dementia, Regardless of Anticoagulation Use
Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions. Researcher and electrophysiologist Jared Bunch, MD, with the Intermountain Medical Center Heart Institute, explains the study, which was presented at the American Heart Association Scientific Sessions in New Orleans.
Просмотров: 76 Healthy Dialogues
Warfarin Anticoagulation, Dementia, and Atrial Fibrillation
DescriptioDr. Malini Madhavan, an Assistant Professor of Cardiology at Mayo Clinic in Rochester, MN, discusses her article appearing in the February 2018 issue of Mayo Clinic Proceedings which examined the effect of anticoagulation in patients experiencing atrial fibrillation and its relationship to dementia. She found significant reductions in the incidence of dementia in those patients maintaining therapeutic levels of warfarin. She notes further studies are needed for the effects of newer anticoagulants. Available at: https://tinyurl.com/ycjvxykkn
Просмотров: 56 Mayo Proceedings
Atrial Fibrillation: Coumadin to Prevent Stroke
One of the potential devastating consequences of atrial fibrillation is a stroke. You can prevent a stroke with the use of a blood thinner called coumadin. HeartSmartMD co-founder, author and board certified cardiologist Dr. Matt DeVane explains the risks and benefits of using coumadin to prevent strokes in atrial fibrillation. Learn much more at www.HeartSmartMD.com
Просмотров: 653 HeartSmartMD
Natural 'Blood thinners' for Afib
This video is about Natural 'Blood thinners' for Afib. In this video, i talk about some natural blood thinners like Garlic, Ginger, Nattokwinase, Hawthorn, Motherwort etc and why i would not recommend them as an alternative to warfarin or the NOACs in patients with Afib
Просмотров: 27754 York Cardiology
Atrial Fibrillation & Coumadin® Replacements--StopAfib.org interviews Dr. Manish Shah
http://www.stopafib.org Dr. Manish Shah talks about Dabigatran and Rivaroxaban, new drugs in clinicals trials to replace the blood thinner Coumadin® (warfarin), an anticoagulant frequently used to avoid strokes by those with atrial fibrillation. He talks about the two categories of these new drugs, thrombin inhibitors and Factor Xa (10a) inhibitors. Dr. Shah is Associate Director of Cardiac Arrhythmia Research at the Washington Hospital Center in Washington, D.C., and Assistant Professor of Medicine at Georgetown University School of Medicine. StopAfib.org, at http://www.StopAfib.org, is for atrial fibrillation patients by afib patients. A full video transcript can be found at: http://stopafib.org/newsitem.cfm/NEWSID/135
Просмотров: 4904 StopAfib
8 atrial fibrillation Management
Просмотров: 18727 drsarmaji
Warfarin, Diet and Atrial Fibrillation
James Edgerton, MD discusses diet changes and warfarin with an atrial fibrillation patient. Learn more about AFib patient education at MyAFibExperience.org
Просмотров: 288 American Heart Association
Managing atrial fibrillation: Anticoagulation, ablation, and improving quality of life
In a video originally posted on TheHeart.org, Win-Kuang Shen, MD, sits down with Samuel J Asirvatham, MD, and Douglas Packer, MD, for an in-depth discussion of the major issues involved in managing atrial fibrillation, from increasing patient awareness to stroke prevention and when and how to use ablation.
Просмотров: 768 Mayo Clinic
Anticoagulation and risk of bleeding with Atrial Fibrillation
Eric Prystowsky, MD explains important points to keep in mind when weighing the risk of stroke and bleeding risk with anticoagulation for AFib patients.
Просмотров: 143 American Heart Association
AFib, anticoagulants and antidotes
In this video, Dr Sanjay Gupta, discusses the role of different anticoagulants in atrial fibrillation and why the lack of antidotes shouls not put anyone off using the NOACS.
Просмотров: 1606 York Cardiology
The two types of Afib
Type 1 and type 2 AF Most medical conditions in the western world are caused by one or more of the following conditions: Age Genetics Luck and Lifestyle. Lets look at diabetes. There is type 1 diabetes which is usually caused by bad genetics or just bad luck and affects young patients and there is type 2 diabetes which affects older patient and is usually caused by age and lifestyle. They are managed differently. Type 1 diabetes is treated with Insulin Type 2 diabetes is treated with tablets/diet and sometimes insulin (and lifestyle changes) In the same way, i believe that there are 2 types of Afib and they are caused by different things but unfortunately they are thought of as one condition and therefore all Afib is managed in the same way but ideally they should be managed differently and if you understand the difference, it may allow you to target those treatments which will give you most benefit. Type 1 Afib. Whilst most patients with Afib is seen in older patients with comorbidities, we do see it in younger patients who have no comorbidites…this has historically been termed lone Afib. In these patients, the reason of Afib is usually genetic or bad luck when you scan these patients they have normal sized left atria and often their Afib comes and goes and interestingly they seem to really not tolerate their Afib very well at all. When you follow them up, they have an exceptionally good prognosis with no increase in stroke risk and these patients seem to respond extremely well to ablation. Type 2 Afib, Older patients with Afib usually tend to develop it because of increased age and bad lifestyle. They often have comorbidites such as diabetes, hypertension, sleep apnoea and vascular disease. Interestingly when you scan their hearts they have big sized left atria and they seem to tolerate their Afib very well. Often many are found to be in Afib incidentally and they are often in persistent Afib. When you follow them up, they do very badly in the short to medium term and have a much higher incidence of strokes, heart failure and even sudden death and therefore need anticoagulation. Often they don’t respond as well to ablation and even if they do they often end up requiring more than one procedure and taking away the Afib does not alter their risk of strokes or overall prognosis. and therefore I think that patients with type 1 Afib should be treated with reassurance and ablation and patients with type 2 A fib do better with anticoagulation and lifestyle modification and ablation in the case of refractory symptoms
Просмотров: 7932 York Cardiology
Atrial Fibrillation in Older Adults: Anticoagulation
November 18th, 2016 Michael A. Chen, MD, PhD Associate Professor of Medicine Division of Cardiology Harborview Medical Center University of Washington
Просмотров: 117 NW GWEC
6/16/17: Atrial Fibrillation: Can We Organize the Chaos?
Anne O'Connor, MD and Jennifer Wright, MD co-present a lecture about clinical management of atrial fibrillation. Dr. O'Connor is an Associate Professor (CHS) whose clinical interests include critical cardiology, reducing readmissions for heart failure and acute myocardial infarct patients, and cardiovascular imaging. Dr. Wright is a Clinical Assistant Professor who specializes in cardiology and electrophysiology. Both are members of the Division of Cardiovascular Medicine in the Department of Medicine at UW-Madison. The title of their June 16, 2017 Grand Rounds talk is "Atrial Fibrillation: Can We Organize the Chaos?" University of Wisconsin Department of Medicine Grand Rounds are presented throughout the academic year and are intended for health care professionals and medical researchers. Unless otherwise indicated, Grand Rounds occurs in the William S. Middleton Memorial Veterans Hospital auditorium, Room A1028, Madison, Wisconsin. All faculty and staff are invited and encouraged to attend. For more information on the Grand Rounds lecture series, visit http://www.medicine.wisc.edu/dom/medicine-grand-rounds
Просмотров: 2657 UW Department of Medicine
New Procedure Treats Atrial Fibrillation Without Blood Thinners
Many Americans take blood thinners to help manage atrial fibrillation. AFib, the most common sustained heart arrhythmia, affecting nearly three million people in the United States, can lead to severe complications like strokes if untreated. Ed Cleary came to Massachusetts General Hospital in June 2012 to get his AFib treated. He had tried taking a blood thinner to help manage his AFib, but bled too much. Fortunately, he qualified for a new procedure now being used for the first time in New England by Mass General Hospital. The Lariat® procedure is for patients who cannot be on blood thinners. The procedure, which is minimally-invasive and uses catheters, ties off the left atrial appendage by use of sutures (blood clots often appear in the LAA and can cause strokes). In this video, Moussa Mansour, MD, director of the Mass General Atrial Fibrillation Program in the Institute for Heart, Vascular and Stroke Care, talks about what the procedure does, gives a general overview of the problem for some patients with the left atrial appendage and shares Mr. Cleary's prognosis. For more information about AFib and diseases and conditions treated in the Atrial Fibrillation Program, visit: http://www.massgeneral.org/heartcenter/services/treatmentprograms.aspx?id=1565.
Просмотров: 12623 MassGeneralHospital
Complete Guide To Atrial Fibrillation: Causes, risks of stroke, medication, symptoms and treatments
Reviews what is atrial fibrillation (afib), how common is afib, what causes afib, how afib causes stroke, what is the risk of stroke with afib, how to calculate your risk of stroke with afib, how to reduce chances of stroke with atrial fibrillation, what is coumadin, what are the risks of coumadin, what are the new anticoagulants available in the market today to treat afib, occlusion devices, when is an occlusion device indicated, the Watchman device, the Lariat Device, what are the symptoms of afib, medications for afib symptoms including amiodarone, the risks of amiodarone, risks and benefits of antiarrhythmics, what is an afib ablation, how are atrial fibrillation ablations done, what is the benefit of an afib abaltion. Written by two cardiologists: Dr. Jorge Romero MD FACC FHRS, electrophysiologist, and Dr. José Taveras MD FACC. Produced by Doctablet. You can find the post for this video at: https://doctablet.com/medicine/cardiology/arrhythmina/afib/afib-series/ Please visit Doctablet for more topics that will supplement the information you see in this video: https://doctablet.com/ Also! You can ask questions related to this topic, we enjoy answering questions, it helps us get feedback and gives us material for future videos. ALSO!, most important! Subscribe to our YouTube Channel! It means the world to https://www.youtube.com/channel/UCiGhz8d21xvPWs7FgLx2sMFA/?sub_confirmation=1
Просмотров: 463 Doctablet
Reasons to take warfarin for Afib
In this video, Dr Sanjay Gupta discusses some important advantages of warfarin for stroke prevention in AFib. My website is yorkcardiology.co.uk and my email is yorkcardiology@gmail.com
Просмотров: 787 York Cardiology
Atrial fibrillation and stroke - the professional perspective
Dr Matthew Fay (GP and AF specialist) and Brendan Young (Patient representative on West Midland Clinical Senate) speak about the importance of anticoagulation for stroke prevention in patients with AF
Просмотров: 833 Stroke Association
Eliquis: New Medication for Atrial Fibrillation
An in-depth conversation between Pentucket Medical cardiologists Seth Bilazarian and Sunny Srivastava, focusing on a newly released medicine to reduce the risks of atrial fibrillation. The latest among recently approved blood thinners, Eliquis joins Pradaxa and Xarelto as an alternative to Coumadin, a drug that has been in use since the 1950s. Like Pradaxa and Xarelto, Eliquis has been shown to reduce risk of stroke and bleeding, as well as mortality. All the new drugs eliminate the need for regular blood testing that Coumadin necessitates.
Просмотров: 30525 PentucketMedical
Heart&Stroke Clinical Update www.heartandstroke.ca/clinicalupdate Hilton Toronto, December 2016 MANAGING ATRIAL FIBRILLATION: BEYOND ANTICOAGULATION Presented by: Peter Leong-Sit MD, MSc, FRCPC, FHRS (see below) Learning Objectives: 1.To review management strategies for atrial fibrillation 2.To identify good candidates for rhythm control or ablation for atrial fibrillation 3.To provide an overview of atrial fibrillation ablation principles 4.To provide an overview of invasive options for stroke prevention Peter Leong-Sit MD, MSc, FRCPC, FHRS Associate Professor Western University Cardiologist London Heart Rhythm Program The following video was provided with the permission of the speaker. The information is intended for the use of healthcare professionals for reference and education only and is not intended to be a substitute for healthcare professional advice, diagnosis or treatment. You should consult your healthcare professional for personal health matters.
Просмотров: 246 Heart and Stroke
Exercise "Dose" and Anticoagulation for AFib
Dr. Christopher Cannon discusses articles appearing this week in Circulation, AJC, and in NEJM on exercise "dose" and on anticoagulation for Afib. Christopher P. Cannon, MD, FACC Statements or opinions expressed in this program reflects the views of the contributors and do not reflect the official policy of the ACCF, unless otherwise noted.
Просмотров: 655 American College of Cardiology
Comparing Eliquis to Warfarin In Atrial Fibrillation Patients
While warfarin has long been a common treatment option for patients with atrial fibrillation new medications are coming to the market which provide different benefits than the original option.
Просмотров: 3757 MD Magazine
Treatments for stroke prevention in atrial fibrillation
This video explains how atrial fibrillation (AF) can cause stroke and why anticoagulation is so important to prevent this. It features AF Association CEO, Trudie Lobban MBE, Deputy CEO, Jo Jerrome, CEO of Anticoagulation Europe, Eve Knight and leading AF specialist, Professor John Camm. Developed in association with Boehringer Ingelheim
Просмотров: 1404 ArrhythmiaAlliance
Diagnosis of Atrial Fibrillation and Anticoagulation therapy
Dr. S Arthnari performs on The main cause of strokes in the elderly is acquired Aortic Stenosis
Просмотров: 35 Revolution Talk
Developing anticoagulation management and therapy for atrial fibrillation through primary care
Atrial fibrillation is the commonest heart rhythm abnormality, substantially raising risk of stroke and death and affecting around 8.8 million people in the EU, with up to 2% of the UK population taking oral anticoagulation medication. Birmingham research has supported a move from lab blood tests and secondary care to primary care and more recently patient self-management through development of new testing and management approaches, which have helped improve clinical outcomes. Clinical trials led in Birmingham have also proven the safety of anticoagulation therapy in elderly patients, and led to the establishment of the National Centre for Anticoagulation Training within the University, which provides accredited training for health care professionals involved in the management of patients.
Просмотров: 197 University of Birmingham
Reducing stroke risk in atrial fibrillation
Atrial fibrillation (AF) increases stroke risk five-fold. This video explains how this risk could be reduced through appropriate anticoagulation. It features Arrhythmia Alliance and AF Association CEO, Trudie Lobban MBE, AF Association Deputy CEO, Jo Jerrome, leading heart rhythm specialist, Professor John Camm and CEO of Anticoagulation Europe, Eve Knight. Developed in association with Boehringer Ingelheim.
Просмотров: 2297 ArrhythmiaAlliance
What are my options for anticoagulation therapy for Atrial Fibrillation?
Mintu Turakhia, MD, MAS, discusses the difference in oral anticoagulants and anticoagulation therapy that includes a clinic or coach. To connect with other patients visit: http://spr.ly/60598YnMv
Просмотров: 158 American Heart Association
Familial Afib, Peri-procedural Anticoagulation and CKD
Familial Afib, Peri-procedural Anticoagulation and CKD
Просмотров: 134 American College of Cardiology
How does warfarin help if I have atrial fibrillation?
Specialist Dr John Worthington talks about the anticoagulant medicine warfarin, including how it reduces the risk of stroke in people with atrial fibrillation. Find out more about warfarin at http://www.nps.org.au/warfarin
Просмотров: 687 NPS MedicineWise
Atrial Fibrillation Anticoagulation - PowerPoint Presentation
http://www.medicaldump.com - Please visit the site for FREE medical PowerPoints, medical PowerPoint templates, medical e-books related to all specialties including ophthalmology, cardiology, neurology, nephrology, GI, etc. This is a Cardiology PowerPoint presentation about Atrial Fibrillation Anticoagulation.
Просмотров: 666 medicaldump
Coumadin (Warfarin): Clinical Pharmacist Explains Everything You Should Know
Dr. Jacqueline DiMarco, clinical pharmacist, explains everything patients should know about the blood thinner Coumadin (warfarin). We cover the mechanism of action against vitamin K, the conditions it treats (including atrial fibrillation and deep vein thrombosis a.k.a DVT), the INR and how it should be monitored, as well as the Lovenox bridge and dietary recommendations. Make sure to check us out on the web at http://www.DoctorVoices.com for the most dependable health information on the internet. This video and all content produced by Doctor Voices is for educational purposes only, please make sure to follow with your doctor for all of your health conditions. Please see our terms of use on our site.
Просмотров: 36616 360 Pain Academy
Meds First Line Treatment for AFib
Cardiovascular disease remains the number one killer in this country, and one of the most commonly seen cardio conditions is AFib. An irregular heartbeat, it leads to a higher risk of stroke. “The risks are completely different depending upon a variety of issues including the history of prior stroke, heart failure, high blood pressure, diabetes, vascular disease, age, and gender,” says Lee Memorial Health System cardiologist Dr. Richard Chazal. With the help of a risk calculator, doctors assess each patient. Much research and development is being aimed towards AFib, but the simple truth is, that one of the most basic, time-tested treatments remains the best first line approach. “In 2014, the American College of Cardiology and the American Heart Association released guidelines on treatment of patients with atrial fibrillation. In most cases, patients with minimal symptoms are recommended to be treated with control of the heart rate and also anticoagulant blood thinners to reduce the likelihood of having a stroke,” says Dr. Chazal. At the same time advances are being made in surgical treatments for AFib, R&D is put to use in developing new drugs. These medications are easier to take than in years past. The hope is more people who need them will find drug therapy easier to swallow. “Their advantage is a reduction in the likelihood of interaction with other medications, a reduction in the likelihood of interaction with certain foods or beverages that could be problematic with warfarin or Coumadin, and importantly, the lack of need for regular blood test to monitor the control of the anticoagulant,” says Dr. Chazal. A risky condition, your doctors can recommend the right line of treatment for AFib that will reduce the stress on your health. View More Health Matters video segments at leememorial.org/healthmatters/ Lee Memorial Health System in Fort Myers, FL is the largest network of medical care facilities in Southwest Florida and is highly respected for its expertise, innovation and quality of care. For nearly a century, we’ve been providing our community with everything from primary care treatment to highly specialized care services and robotic assisted surgeries. Visit leememorial.org
Просмотров: 2567 Lee Health
The Latest News about Atrial Fibrillation
Dr. Rajat Deo, a cardiovascular medicine doctor at Penn Heart and Vascular, discusses how new and better drugs will be replacing Coumadin to help atrial fibrillation patients avoid strokes. These drugs have fewer side effects and less of a need for careful monitoring. Learn more about the services at Penn Heart and Vascular: http://www.pennmedicine.org/heart/patient/clinical-services/ View Dr. Rajat Deo's profile: http://www.pennmedicine.org/wagform/mainpage.aspx?config=provider&p=pp&id=11092 Dr. Deo was interviewed by Andrew Schorr, host and founder of Patient Power, at the 2010 American Heart Association (AHA) annual meeting.
Просмотров: 1053 Penn Medicine
Can I take an aspirin for atrial fibrillation?
Join our channel by subscribing here. If you have enjoyed our video, please like it and leave a comment about what other videos you may be interested in. Your help in creating great, relevant content is greatly appreciated. Although it was thought for many years that aspirin was sufficient to 'thin' your blood to prevent blood clots inside the heart from forming, the latest evidence is that aspirin is just not effective enough in people who have atrial fibrillation associated with other risk factors, including being elderly! This video describes the role of aspirin in managing patients with atrial fibrillation. Transcript: Thank you for visiting Doctor AFib, I'm Dr. Morales. In today's video segment we're going to be talking about the role of aspirin when it comes to managing atrial fibrillation. In a previous video segment, I discussed your risk of stroke with atrial fibrillation as defined by the CHADSVASc risk score. Most people who have atrial fibrillation are going to have a CHADSVASc score of two or greater and it's going to be recommended to take stronger blood thinners, something called anticoagulation. However, when I explain it to the patients, probably the next question is: what about an aspirin? Can I take an aspirin for atrial fibrillation? So, let's look at the data regarding aspirin for atrial fibrillation. Aspirin has been studied for atrial fibrillation since the late 80s and early 90s and in multiple clinical trials. Back in 2007, there was a meta-analysis which combined the results of several studies and showed that aspirin provides a reduction in the rate of stroke by about 22%. Most studies in the 80s and 90s used aspirin 325 milligrams daily. A later study called the Active W trial looked at the combination of aspirin together with Plavix and that reduced your risk of stroke by about 44%. However, in that same meta-analysis in 2007, it showed that Warfarin, also called Coumadin, reduced risk of stroke in atrial fibrillation by about 66%. Several studies were done back in the late 80s or 90s early 2000s looking at comparing aspirin with Warfarin and every time Warfarin was found to be superior to aspirin for reducing your risk of stroke. As a result, for many years Warfarin became the standard of care for reducing the risk of stroke because it was far better in terms of the reduction amount for reducing the risk of stroke. Fortunately, these days there are other options, where newer blood thinners have come out as an alternative to Warfarin. Listen to the video for more Read my blog posts at http://www.DrAFib.com
Просмотров: 371 Doctor AFib
Session 7: Atrial fibrillation in the ED - Can We Do More? (Cardioversion, Anticoagulation)
Speaker: A/Prof Ching Chi Keong Date: 28th February 2016
Просмотров: 148 SEMSingapore
Coumadin vs aspirin for a fib by Dr  Tadi
Просмотров: 3 Doctor Tadi
Catheter Ablation of Atrial Fibrillation
Dr. Kneller discusses comprehensive management strategy for atrial fibrillation, including anticoagulation, anti-arrhythmic drug therapy, continuous monitoring of atrial fibrillation with the Medtronic Reveal LINQ, and strategies for catheter ablation of atrial fibrillation including optimal use of the CARTO V3 mapping system.
Просмотров: 3473 JamesKnellerMD
B. Lüderitz - History of Anticoagulation - 12° International Meeting Atrial Fibrillation 2017
History of Anticoagulation - From the Beginning to Direct Oral Anticoagulants B. Lüderitz 12° International Meeting Atrial Fibrillation 2017 - Atrial Fibrillation and Heart Failure: the ugly and the nasty February 16/17, 2017 Royal Hotel Carlton Bologna - Italy
Просмотров: 23 Cardio Cardiotool